Skip to main content
Clinical Trials/NCT00329615
NCT00329615CompletedPhase 4

Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.

Göteborg University2 sites in 1 country135 target enrollmentStarted: January 1, 2000Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
135
Locations
2
Primary Endpoint
Health related quality of life,

Study Overview

Brief Summary

The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.

Detailed Description

Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic efficiency.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
25 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Weight loss
  • Systemic solid cancer

Exclusion Criteria

  • Brain metastases
  • Expectant survival of less than 6 months
  • Serum creatinine above 200 umol/l
  • Persistent of recurrent fever
  • Cholestasis

Outcomes

Primary Outcomes

Health related quality of life,

food intake,

resting energy expenditure,

body composition,

metabolic efficiency,

spontaneous physical activity,

blood and hormonal tests

serum tumor markers

Secondary Outcomes

  • Survival

Investigators

Sponsor
Göteborg University
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials